Search
for

    GlossaryKX826

    KX826 is a novel topical treatment developed for androgenetic alopecia, commonly known as male or female pattern hair loss. It functions as a dual-action agent, targeting both the androgen receptors and promoting hair follicle growth, which distinguishes it from traditional treatments like minoxidil and finasteride. Its relevance lies in its potential to offer a more effective solution for hair regrowth by addressing the hormonal factors contributing to hair loss while also stimulating hair follicle activity. Clinical trials have shown promising results, making KX826 a noteworthy option in the evolving landscape of hair loss therapies.

    Related Terms

    Sort by

    Community Join

    30 / 374 results

      community KX826 New Phase 3 Trial In China for 2025: 1.0% concentration

      in Research/Science  60 upvotes 1 year ago
      KX-826 is undergoing Phase III trials in China as a potential treatment for male pattern baldness, with some users considering it as an alternative or addition to finasteride and dutasteride. Opinions on its effectiveness vary, with some users reporting positive results and others finding it expensive and ineffective.

      community GT20029 & KX826 Major Updates from Kintor.

      in Research/Science  102 upvotes 1 year ago
      KX826 shows promise as a hair loss treatment with a 10% increase in hair count, but concerns about Kintor's marketing practices and the systemic effects of treatments like GT20029 and RU58841 remain. Users express skepticism and hope, with some preferring traditional treatments like finasteride and minoxidil.

      community KX-826 Phase 3 Results Are Out

      in Research/Science  107 upvotes 4 weeks ago
      KX-826 shows promising results for hair growth with fewer side effects, offering an alternative to finasteride and minoxidil. Users discuss combining it with minoxidil, dermarolling, and Nizoral for improved results.

      community KX-826 , a small change in the pipeline

      in Research/Science  6 upvotes 2 months ago
      KX-826 is undergoing trials for hair loss treatment, showing similar effectiveness between 0.5% and 1.0% dosages, with mild side effects compared to finasteride. Users discuss combining KX-826 with other treatments like minoxidil and clascoterone for better results.

      community KX-826 users: 0.5% vs 0.9% vs foam

      in Technology  6 upvotes 8 months ago
      KX-826 is being discussed for hair loss treatment, with users debating between 0.5% and 0.9% solutions and foam. Some report side effects like headaches, while others see no changes; it blocks androgen receptors without reducing DHT levels.

      community KX-826 Pyrilutamide1% coming soon

      in Update  152 upvotes 1 year ago
      KX-826 Pyrilutamide 1% is launching soon, and users are discussing its potential benefits and drawbacks compared to other treatments like Minoxidil and finasteride. Some users are skeptical about its effectiveness, while others are hopeful it will be a safer alternative.

      community KX-826. What have been your experiences?

      in Product  1 upvotes 2 weeks ago
      KX-826 may cause increased hair loss for some users, leading to concerns about its effects. One user reported no issues but also no hair regrowth, only maintenance.

      community KX-826 alone to stop hairloss???

      in Treatment  13 upvotes 5 months ago
      A 28-year-old male experiencing early male pattern baldness is considering using Pyrilutamide (KX-826) as an alternative to finasteride due to side effects. He seeks to maintain his current hair without regrowth and is concerned about potential side effects like reduced libido.

      community KX-826 1% Phase II Results from China Just Dropped

      in Research/Science  36 upvotes 8 months ago
      KX-826 (Pyrilutamide) 0.5% and 1.0% solutions showed promising results in increasing hair count for male androgenetic alopecia, with the 0.5% dose slightly outperforming the 1% dose. The treatment was well-tolerated with no sexual side effects, but skepticism remains due to past inconsistencies in trial results.

      community KX-826 Max Version--Can This Formula Truly Combat Hairloss?

      in Product  3 upvotes 8 months ago
      KX-826 Max combines KX-826, Kopyrrol, and Kopexil as a potential alternative to minoxidil and finasteride for hair loss, but users express skepticism about its effectiveness and high cost. Some users believe traditional treatments like minoxidil, finasteride, and others are more reliable.

      community Is .5% kx-826 worthless? Koshine vs RU

      in Research/Science  3 upvotes 1 year ago
      Kx-826 at 0.5% shows limited effectiveness for hair loss, while 1% is more promising but expensive. RU58841 is considered a more feasible option until 1% kx-826 becomes affordable.

      community KX-826 seems to be working for me

      in Product  1 upvotes 1 year ago
      KX-826 stopped hair loss for the user after stopping finasteride due to mild side effects. The user experienced mild headaches initially with KX-826, which resolved after a few days.

      community Anyone have any KX-826 results yet?

      in Product  14 upvotes 1 year ago
      KX-826 users report increased shedding, with some experiencing more shedding at higher concentrations. Users are discussing where to purchase the product.

      community KX-826: Long-Term Safety Results are out!

      in Research/Science  158 upvotes 1 year ago
      KX-826 initially improves hair growth but declines after 24 weeks, with mild itching as a side effect. Combining it with minoxidil and finasteride may improve results, but long-term effectiveness is uncertain.

      community KX-826 (Pyrilutamide) on Amazon

      in Treatment  9 upvotes 1 year ago
      The conversation is about purchasing KX-826 (Pyrilutamide) on Amazon, now called Koshine. A user mentioned their order is expected to arrive between August 22 and September 13.

      community Why I still have faith in KX-826

      in Research/Science  54 upvotes 1 year ago
      KX-826 shows promise for hair maintenance at higher doses with minimal side effects, despite failing Phase III trials. The user believes it is more effective than Minoxidil, Finasteride, and RU58841.

      community KX-826 Phase 3 Failed. Sorry guys...

      in Research/Science  50 upvotes 2 years ago
      The conversation discusses the failure of Phase 3 trials for the hair loss treatment KX-826, with no significant difference found between the drug and placebo. Some users express disappointment and skepticism, while others discuss alternative treatments like Minoxidil, finasteride, and RU58841.

      community KX 826 x Hair Loss - The Last Dance

      in Satire  8 upvotes 3 years ago
      The conversation humorously discusses hair loss treatments, mentioning Minoxidil, finasteride, and RU58841. It suggests that affordable genetic therapy could be the ultimate solution.